tirzepatide microdosing chart Instructions for Compounded Tirzepatide+ dosing for tirzepatide Microdosing Chart:

Tirzepatide is a novel glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist approved by the FDA for the treatment of type 2 diabetes mellitus and chronic weight management

You've invested in a high-purity research compound, and now you're staring at a small vial, wondering, "Does BPC 157 nasal spray really need to be refrigerated?" The internet is a sprawling landscape of conflicting advice, with some claiming it's fine on a countertop and others insisting on sub-zero temperatures

Exciting stuff

GLP-1s Show Promise Against Addiction Arguably the most unexpected off-target benefit of GLP-1 receptor agonists on this list is their potential protective effects in addictive disorders